| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.
|
N Engl J Med
|
2003
|
13.29
|
|
2
|
Protected carotid-artery stenting versus endarterectomy in high-risk patients.
|
N Engl J Med
|
2004
|
12.58
|
|
3
|
Lack of association between migraine headache and patent foramen ovale: results of a case-control study.
|
Circulation
|
2010
|
2.88
|
|
4
|
The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS).
|
J Am Coll Cardiol
|
2004
|
2.78
|
|
5
|
A blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease.
|
J Am Coll Cardiol
|
2005
|
2.56
|
|
6
|
Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts.
|
Circulation
|
2002
|
2.53
|
|
7
|
Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis.
|
Circulation
|
2004
|
2.35
|
|
8
|
Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial.
|
Circulation
|
2004
|
2.28
|
|
9
|
The reporting of blinding in physical medicine and rehabilitation randomized controlled trials: a systematic review.
|
J Rehabil Med
|
2013
|
2.20
|
|
10
|
Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial.
|
JAMA
|
2006
|
2.16
|
|
11
|
Cost-effectiveness of distal embolic protection for patients undergoing percutaneous intervention of saphenous vein bypass grafts: results from the SAFER trial.
|
J Am Coll Cardiol
|
2004
|
2.05
|
|
12
|
Effect of endothelial shear stress on the progression of coronary artery disease, vascular remodeling, and in-stent restenosis in humans: in vivo 6-month follow-up study.
|
Circulation
|
2003
|
2.04
|
|
13
|
Coronary artery spatial distribution of acute myocardial infarction occlusions.
|
Circulation
|
2004
|
1.96
|
|
14
|
Medical device development: from prototype to regulatory approval.
|
Circulation
|
2004
|
1.90
|
|
15
|
Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy.
|
Circulation
|
2004
|
1.83
|
|
16
|
Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials.
|
Circulation
|
2004
|
1.72
|
|
17
|
Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison.
|
Circulation
|
2005
|
1.67
|
|
18
|
Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials.
|
J Am Coll Cardiol
|
2002
|
1.62
|
|
19
|
Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial.
|
Circulation
|
2006
|
1.62
|
|
20
|
Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia.
|
Circulation
|
2002
|
1.61
|
|
21
|
Incidence and predictors of late total occlusion following coronary stenting.
|
Catheter Cardiovasc Interv
|
2003
|
1.61
|
|
22
|
Saphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled analysis of 3958 patients.
|
Circulation
|
2008
|
1.59
|
|
23
|
A decade of improvement in the clinical outcomes of percutaneous coronary intervention for multivessel coronary artery disease.
|
Circulation
|
2002
|
1.58
|
|
24
|
Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial.
|
J Am Coll Cardiol
|
2006
|
1.56
|
|
25
|
Treatment of left anterior descending coronary artery disease with sirolimus-eluting stents.
|
Circulation
|
2004
|
1.54
|
|
26
|
Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the sirius trial.
|
J Am Coll Cardiol
|
2004
|
1.53
|
|
27
|
Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures.
|
J Am Coll Cardiol
|
2004
|
1.52
|
|
28
|
Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction.
|
J Am Coll Cardiol
|
2002
|
1.51
|
|
29
|
Post-market approval surveillance: a call for a more integrated and comprehensive approach.
|
Circulation
|
2004
|
1.49
|
|
30
|
Cost-effectiveness of gamma radiation for treatment of in-stent restenosis: results from the Gamma-1 trial.
|
Circulation
|
2002
|
1.48
|
|
31
|
Location of acute coronary artery thromboses in patients with and without chronic kidney disease.
|
Kidney Int
|
2008
|
1.44
|
|
32
|
Surrogates, substudies, and real clinical end points in trials of drug-eluting stents.
|
J Am Coll Cardiol
|
2005
|
1.43
|
|
33
|
Platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment during saphenous vein graft stenting: differential effects after randomization to occlusion or filter-based embolic protection.
|
Eur Heart J
|
2006
|
1.42
|
|
34
|
The SIRIUS-DIRECT trial: a multi-center study of direct stenting using the sirolimus-eluting stent in patients with de novo native coronary artery lesions.
|
Catheter Cardiovasc Interv
|
2007
|
1.38
|
|
35
|
Prediction of sites of coronary atherosclerosis progression: In vivo profiling of endothelial shear stress, lumen, and outer vessel wall characteristics to predict vascular behavior.
|
Curr Opin Cardiol
|
2003
|
1.29
|
|
36
|
Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts.
|
Circulation
|
2003
|
1.27
|
|
37
|
Meta-analysis of corticosteroid treatment in acute myocardial infarction.
|
Am J Cardiol
|
2003
|
1.20
|
|
38
|
Reproducibility of coronary lumen, plaque, and vessel wall reconstruction and of endothelial shear stress measurements in vivo in humans.
|
Catheter Cardiovasc Interv
|
2003
|
1.20
|
|
39
|
Quantitative assessment of angiographic restenosis after sirolimus-eluting stent implantation in native coronary arteries.
|
Circulation
|
2004
|
1.20
|
|
40
|
Network news: powering clinical research.
|
Sci Transl Med
|
2013
|
1.19
|
|
41
|
Two-year outcomes after sirolimus-eluting stent implantation: results from the Sirolimus-Eluting Stent in de Novo Native Coronary Lesions (SIRIUS) trial.
|
J Am Coll Cardiol
|
2006
|
1.18
|
|
42
|
Distribution of coronary artery disease and relation to mortality in asymptomatic hemodialysis patients.
|
Am J Kidney Dis
|
2007
|
1.14
|
|
43
|
The use of invasive cardiac procedures after acute myocardial infarction in long-term dialysis patients.
|
Am Heart J
|
2006
|
1.13
|
|
44
|
Randomized trial of 90Sr/90Y beta-radiation versus placebo control for treatment of in-stent restenosis.
|
Circulation
|
2002
|
1.11
|
|
45
|
Robustness of late lumen loss in discriminating drug-eluting stents across variable observational and randomized trials.
|
Circulation
|
2005
|
1.10
|
|
46
|
Long-term outcome of patients treated with repeat percutaneous coronary intervention after failure of gamma-brachytherapy for the treatment of in-stent restenosis.
|
Circulation
|
2002
|
1.08
|
|
47
|
Relationship of late loss in lumen diameter to coronary restenosis in sirolimus-eluting stents.
|
Circulation
|
2005
|
1.04
|
|
48
|
Effects of stent length and lesion length on coronary restenosis.
|
Am J Cardiol
|
2004
|
1.02
|
|
49
|
Regions of low endothelial shear stress are the sites where coronary plaque progresses and vascular remodelling occurs in humans: an in vivo serial study.
|
Eur Heart J
|
2007
|
1.02
|
|
50
|
Remodeling characteristics of minimally diseased coronary arteries are consistent along the length of the artery.
|
Am J Cardiol
|
2005
|
1.02
|
|
51
|
Risk assessment for percutaneous coronary intervention: our version of the weather report?
|
J Am Coll Cardiol
|
2003
|
1.01
|
|
52
|
Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Cardiac enzyme elevation after successful percutaneous coronary intervention is not an independent predictor of adverse outcomes.
|
Circulation
|
2005
|
1.00
|
|
53
|
Periprocedural and late consequences of overlapping Cypher sirolimus-eluting stents: pooled analysis of five clinical trials.
|
J Am Coll Cardiol
|
2006
|
0.92
|
|
54
|
The changing structure of industry-sponsored clinical research: pioneering data sharing and transparency.
|
Ann Intern Med
|
2013
|
0.91
|
|
55
|
ACC/AHA 2007 methodology for the development of clinical data standards: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards.
|
J Am Coll Cardiol
|
2007
|
0.89
|
|
56
|
First-in-human study of the Endeavor ABT-578-eluting phosphorylcholine-encapsulated stent system in de novo native coronary artery lesions: Endeavor I Trial.
|
EuroIntervention
|
2005
|
0.88
|
|
57
|
Embolic protection with filtering or occlusion balloons during saphenous vein graft stenting retrieves identical volumes and sizes of particulate debris.
|
Circulation
|
2004
|
0.87
|
|
58
|
Sirolimus-eluting stents at two years: a pooled analysis of SIRIUS, E-SIRIUS, and C-SIRIUS with emphasis on late revascularizations and stent thromboses.
|
Am J Cardiol
|
2006
|
0.87
|
|
59
|
Determinants of 30-day adverse events following saphenous vein graft intervention with and without a distal occlusion embolic protection device.
|
Am J Cardiol
|
2005
|
0.85
|
|
60
|
Six-month outcomes after percutaneous intervention for lesions in aortocoronary saphenous vein grafts using distal protection devices: results from the FIRE trial.
|
Am Heart J
|
2006
|
0.84
|
|
61
|
Risks of coronary artery bypass surgery in dialysis-dependent patients--analysis of the 2001 National Inpatient Sample.
|
Nephrol Dial Transplant
|
2007
|
0.84
|
|
62
|
Sample size calculation for a historically controlled clinical trial with adjustment for covariates.
|
J Biopharm Stat
|
2002
|
0.83
|
|
63
|
Comparison of rotational atherectomy with conventional balloon angioplasty in the prevention of restenosis of small coronary arteries: results of the Dilatation vs Ablation Revascularization Trial Targeting Restenosis (DART).
|
Am Heart J
|
2003
|
0.83
|
|
64
|
Zotarolimus (ABT-578) eluting stents.
|
Adv Drug Deliv Rev
|
2006
|
0.83
|
|
65
|
Utility of the Safe-Cross-guided radiofrequency total occlusion crossing system in chronic coronary total occlusions (results from the Guided Radio Frequency Energy Ablation of Total Occlusions Registry Study).
|
Am J Cardiol
|
2004
|
0.82
|
|
66
|
Zotarolimus-eluting stents in patients with native coronary artery disease: clinical and angiographic outcomes in 1,317 patients.
|
Am J Cardiol
|
2007
|
0.82
|
|
67
|
Comparison of late luminal loss response pattern after sirolimus-eluting stent implantation or conventional stenting.
|
Circulation
|
2004
|
0.82
|
|
68
|
Cutting balloon angioplasty for the prevention of restenosis: results of the Cutting Balloon Global Randomized Trial.
|
Am J Cardiol
|
2002
|
0.82
|
|
69
|
A meta-analysis of randomized controlled trials of intracoronary gamma- and beta-radiation therapy for in-stent restenosis.
|
Heart Vessels
|
2006
|
0.81
|
|
70
|
Humanitarian Use Devices/Humanitarian Device Exemptions in cardiovascular medicine.
|
Circulation
|
2005
|
0.81
|
|
71
|
Understanding the drug-eluting stent trials.
|
Am J Cardiol
|
2007
|
0.80
|
|
72
|
Effect of catheter-based iridium-192 gamma brachytherapy on the added risk of restenosis from diabetes mellitus after intervention for in-stent restenosis (subanalysis of the GAMMA I Randomized Trial).
|
Am J Cardiol
|
2002
|
0.80
|
|
73
|
Feasibility trial of carotid stenting with and without an embolus protection device.
|
J Endovasc Ther
|
2005
|
0.80
|
|
74
|
Safety of sirolimus-eluting stenting and its effect on restenosis in patients with unstable angina pectoris (a SIRIUS substudy).
|
Am J Cardiol
|
2007
|
0.79
|
|
75
|
Measuring percutaneous coronary intervention quality by simple case volume.
|
Circulation
|
2005
|
0.79
|
|
76
|
Coronary drug-eluting stent development: issues in trial design.
|
Am Heart J
|
2005
|
0.79
|
|
77
|
Prospective, randomized evaluation of thrombectomy prior to percutaneous intervention in diseased saphenous vein grafts and thrombus-containing coronary arteries.
|
J Am Coll Cardiol
|
2003
|
0.79
|
|
78
|
The fate of patients with clinical recurrence after sirolimus-eluting stent implantation (a two-year follow-up analysis from the SIRIUS trial).
|
Am J Cardiol
|
2006
|
0.78
|
|
79
|
Safety of direct stenting with the Endeavor stent: results of the Endeavor II continued access registry.
|
EuroIntervention
|
2007
|
0.78
|
|
80
|
Distal filter protection during saphenous vein graft stenting: technical and clinical correlates of efficacy.
|
J Am Coll Cardiol
|
2002
|
0.78
|
|
81
|
Safety and efficacy of the 2.25-mm sirolimus-eluting Bx Velocity stent in the treatment of patients with de novo native coronary artery lesions: the SIRIUS 2.25 trial.
|
Am J Cardiol
|
2006
|
0.77
|
|
82
|
Treatment of coronary stent thrombosis with rheolytic thrombectomy: results from a multicenter experience.
|
Catheter Cardiovasc Interv
|
2003
|
0.77
|
|
83
|
Two-year clinical follow-up of 90Sr/90 Y beta-radiation versus placebo control for the treatment of in-stent restenosis.
|
Am Heart J
|
2005
|
0.77
|
|
84
|
Comparison of thrombosis and restenosis risk from stent length of sirolimus-eluting stents versus bare metal stents.
|
Am J Cardiol
|
2005
|
0.77
|
|
85
|
ACC/AHA 2007 methodology for the development of clinical data standards: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards.
|
Circulation
|
2007
|
0.77
|
|
86
|
Detailed intravascular ultrasound analysis of Zotarolimus-eluting phosphorylcholine-coated cobalt-chromium alloy stent in de novo coronary lesions (results from the ENDEAVOR II trial).
|
Am J Cardiol
|
2007
|
0.76
|
|
87
|
Percutaneous coronary intervention-induced emboli during primary PCI for STEMI: too little, too much, or too late?
|
Am Heart J
|
2005
|
0.75
|
|
88
|
Effect of gender on in-hospital and one-year outcomes after contemporary coronary artery stenting.
|
Am J Cardiol
|
2005
|
0.75
|
|
89
|
Letter by Kereiakes et al regarding article, "Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern".
|
Circulation
|
2007
|
0.75
|
|
90
|
Relationship of chronic kidney disease to cardiovascular death and myocardial infarction following coronary stenting.
|
J Nephrol
|
2006
|
0.75
|
|
91
|
Safety and efficacy of a novel device for treatment of thrombotic and atherosclerotic lesions in native coronary arteries and saphenous vein grafts: results from the multicenter X-Sizer for treatment of thrombus and atherosclerosis in coronary applications trial (X-TRACT) study.
|
Catheter Cardiovasc Interv
|
2003
|
0.75
|
|
92
|
Rationale and design of the MASS COMM trial: A randomized trial to compare percutaneous coronary intervention between MASSachusetts hospitals with cardiac surgery on-site and COMMunity hospitals without cardiac surgery on-site.
|
Am Heart J
|
2011
|
0.75
|
|
93
|
The effect of intracoronary fibroblast growth factor-2 on restenosis after primary angioplasty or stent placement in a pig model of atherosclerosis.
|
Clin Cardiol
|
2002
|
0.75
|
|
94
|
Application of models for multivariate mixed outcomes to medical device trials: coronary artery stenting.
|
Stat Med
|
2003
|
0.75
|
|
95
|
Relative spatial distributions of coronary artery bypass graft insertion and acute thrombosis: a model for protection from acute myocardial infarction.
|
Am Heart J
|
2010
|
0.75
|
|
96
|
Clinical and angiographic outcomes after use of 90Strontium/90Yttrium beta radiation for the treatment of in-stent restenosis: results from the Stents and Radiation Therapy 40 (START 40) registry.
|
Int J Radiat Oncol Biol Phys
|
2002
|
0.75
|
|
97
|
Comparison of the CardioShield filter with the guardwire balloon in the prevention of embolisation during vein graft intervention: results from the CAPTIVE randomised trial.
|
EuroIntervention
|
2006
|
0.75
|